Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 471 participants.
Also called NCT03738761
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 471 participants
- Registry
-
NCT03738761 -
2017-001596-23
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Armenia, Croatia, Hungary, Poland, Russia, Serbia, Slovenia
- Registry status
- Completed
Technical summary
Registry record NCT03738761. Non-randomized; no masking; primary purpose treatment. Start 2018-02-13 (actual); primary completion 2019-09-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
- Acronym
- PRECIOUS
- Condition
- Hypertension
- Intervention (Drug)
- Amlessa®
- Intervention (Drug)
- Co-Amlessa®
- Lead sponsor
- KRKA
- Collaborator
- Clinres Farmacija d.o.o.
- Collaborator
- University Medical Centre Ljubljana
Record details
- Record id
cardio:ct-nct03738761- Content hash
c1edae8839e8e8f302a62cdc23921b1c6f9d10143cadbe64bcaac0f36a8a33d0